Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kenya Veterinary Vaccines Production Institute (KEVEVAPI) is a state-owned enterprise under the Ministry of Agriculture and Livestock Development of Kenya, dedicated to the research, development, and manufacture of veterinary vaccines. Established in 1990, the institute centralizes the production of essential biologics to safeguard livestock health and enhance food security within Kenya and the broader East African region. KEVEVAPI operates specialized production units in Kabete, Tigoni, and Embakasi, producing a diverse portfolio of vaccines for viral and bacterial diseases such as Foot and Mouth Disease and Newcastle Disease. The organization serves as a critical link in the livestock value chain, providing affordable and high-quality vaccines to smallholder farmers and large-scale producers alike. Its facilities are equipped for large-scale fermentation and cell culture processes required for high-titer vaccine production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kenya Veterinary Vaccines Production Institute.